First Republic Investment Management, Inc. Avid Bioservices, Inc. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$13.48 - $18.79 $11,269 - $15,708	-836 Reduced 5.42%	14,586 $273,000
Q4 2022 Feb 13, 2023	BUY	$12.61 - $18.74 $17,666 - $26,254	1,401 Added 9.99%	15,422 $212,000
Q3 2022 Nov 03, 2022	SELL	$15.33 - $20.36 $260 - $346	-17 Reduced 0.12%	14,021 $268,000
Q2 2022 Aug 16, 2022	BUY	$11.63 - $21.55 $6,501 - $12,046	559 Added 4.15%	14,038 $214,000
Q1 2022 May 16, 2022	SELL	$16.63 - $27.73 $7,150 - $11,923	-430 Reduced 3.09%	13,479 $275,000
Q4 2021 Feb 09, 2022	SELL	$20.7 - $34.18 $39,392 - $65,044	-1,903 Reduced 12.04%	13,909 $406,000
Q3 2021 Nov 12, 2021	SELL	$19.05 - $28.32 $6,324 - $9,402	-332 Reduced 2.06%	15,812 $341,000
Q2 2021 Aug 16, 2021	SELL	$18.93 - $25.65 $5,281 - $7,156	-279 Reduced 1.7%	16,144 $414,000
Q1 2021 May 14, 2021	BUY	$11.86 - $21.77 $194,776 - $357,528	16,423 New	16,423 $299,000

Others Institutions Holding CDMO

# of Institutions

209

Shares Held

67.1M

Call Options Held

216K

Put Options Held

4.6K

Black Rock Inc. New York, NY

5.11M
Shares

$63.8 Million
0.0% of portfolio
Altra Vue Capital, LLC Bellevue, WA

3.8M
Shares

$47.4 Million
4.5% of portfolio
Vanguard Group Inc Valley Forge, PA

3.77M
Shares

$47.1 Million
0.0% of portfolio
Glazer Capital, LLC New York, NY

3.72M
Shares

$46.4 Million
3.11% of portfolio
Punch & Associates Investment Management, Inc. Edina, MN

2.88M
Shares

$36 Million
2.11% of portfolio

View Full List

About Avid Bioservices, Inc.

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $776M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

More about CDMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account